Babesiosis Vaccines: Lessons Learned, Challenges Ahead, and Future Glimpses.

Trends Parasitol

Department of Microbiology, Biomedicine Discovery Institute, Monash University, Victoria 3800, Australia. Electronic address:

Published: August 2019

The incidence and prevalence of babesiosis in animals and humans is increasing, yet prevention, control, or treatment measures remain limited and ineffective. Despite a growing body of new knowledge of the biology, pathogenicity, and virulence of Babesia parasites, there is still no well-defined, adequately effective and easily deployable vaccine. While numerous published studies suggest that the development of such anti-Babesia vaccines should be feasible, many others identify significant challenges that need to be overcome in order to succeed. Here, we review historic and recent attempts in babesiosis vaccine discovery to avoid past pitfalls, learn new lessons, and provide a roadmap to guide the development of next-generation babesiosis vaccines.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pt.2019.06.002DOI Listing

Publication Analysis

Top Keywords

babesiosis vaccines
8
babesiosis
4
vaccines lessons
4
lessons learned
4
learned challenges
4
challenges ahead
4
ahead future
4
future glimpses
4
glimpses incidence
4
incidence prevalence
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!